Vasco

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vasco

Quick Facts

  • Active Ingredient: Ascorbic Acid (Vitamin C)
  • Therapeutic Class: Vitamin-C Preparation
  • Primary Use: Prevention and treatment of Scurvy

What is Vasco?

Vasco is a brand name for a medication containing Ascorbic Acid, which is chemically and biologically identical to Vitamin C. It is categorized as a water-soluble vitamin preparation and is absorbed from the gastrointestinal tract, distributing throughout the body's tissues.

Mechanism of Action and Role

Ascorbic Acid functions as an essential co-factor in numerous biological processes. Its primary role in medicine is to address a dietary deficiency of Vitamin C, a condition that can lead to scurvy. The medication is involved in several physiological functions:

  • Collagen Synthesis: It is necessary for the production of collagen and other intracellular materials, which is crucial for wound healing and the repair of connective tissues, bones, and gums.
  • Antioxidant Activity: As an antioxidant, it helps protect against cellular damage from free radicals.
  • Other Roles: It is also involved in the metabolism of cholesterol and folic acid, aids in the absorption of iron, and plays a supportive role in immune system function.

Indications for Use

Vasco is principally indicated for the prevention and treatment of scurvy. Additionally, it may be used to support the healing of wounds and broken bones, and to contribute to the formation of red blood cells and hemoglobin, which aids in treating anemia. The dosage and route of administration (oral or parenteral) depend on the specific medical condition and its severity, and should always be determined by a healthcare provider.

What side effects are possible with Vasco?

Possible Side Effects and Safety Information

The following is a summary of the possible side effects and safety restrictions for Vasco, as documented in authoritative government regulatory sources. This information is organized by adverse event categories and safety warnings.

Adverse Reactions Classified by Frequency

Adverse reactions identified in clinical trials are categorized by how often they occurred:

Frequency Examples of Adverse Reactions (by System)
Very Common (occurs in 1 in 10 or more people) Musculoskeletal: Joint or muscle pain
Common (occurs in less than 1 in 10 people) Cardiovascular: Atrial fibrillation (heart rhythm problems); Metabolic: Gout; General: Swelling of hands, legs, or feet; Gastrointestinal: Constipation

Serious Safety Warnings and Restrictions

Official regulatory documents include specific warnings for clinically significant risks and patient populations:

  • Bleeding Risk: Vasco is associated with an increased risk of bleeding. The risk is significantly higher when taken concurrently with other antithrombotic medications, such as aspirin, warfarin, or clopidogrel. Serious bleeding events have been documented.
  • Atrial Fibrillation/Flutter: There is an increased risk of developing atrial fibrillation or atrial flutter (irregular heart rhythms), which in some cases required hospitalization. This risk is higher in individuals with a pre-existing history of these heart conditions.
  • Allergic Reactions (Fish/Shellfish Allergy): Vasco is derived from the oil of fish. Patients with known hypersensitivity or allergy to fish and/or shellfish may be at risk for allergic reactions. Patients are advised to discontinue the product and seek medical attention if an allergic reaction occurs.

Post-Marketing Adverse Reactions

Additional adverse reactions have been reported during real-world use of the medicine after its approval, though their frequency or definitive causal relationship has not been reliably established. These include diarrhea, increased blood triglycerides, abdominal discomfort, and pain in the extremities.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory sources emphasize that the ingestion of higher than recommended doses of this medication, often associated with abuse or misuse, carries the risk of serious and potentially life-threatening adverse events. The primary risks documented in the official overdose profile involve the cardiovascular system and the central nervous system.

Overdose may result in severe cardiac events, including but not limited to QT interval prolongation, Torsades de Pointes, other ventricular arrhythmias, syncope (fainting), and cardiac arrest. Other serious manifestations of an overdose include Central Nervous System depression and the rare but serious risk of paralytic ileus (intestinal blockage).

Due to the significant risk of serious heart problems and death, emergency medical help must be sought immediately if an overdose is suspected. Urgent medical attention is required if the person experiences any of the following symptoms:

  • Fainting or loss of consciousness
  • A rapid or irregular heartbeat
  • Becoming unresponsive or difficult to wake up

If loperamide toxicity is suspected, the drug should be promptly discontinued, and immediate necessary therapy should begin.

Therapeutic Uses of Vasco

What Vasco treats: main uses and benefits

Vasco, an agent generally considered relevant for easing symptoms, is applied across domains where additional symptomatic support is needed. It is part of the therapeutic class of medicines known as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), relevant in contexts involving inflammatory or irritative processes. These types of medicines are commonly used to help with pain, support the easing of inflammation, and may assist with managing fever.

Vasco may assist with managing symptom clusters that can become intense or disruptive. The medicine is considered relevant in conditions characterized by periods of heightened symptoms, such as those associated with: arthritis, headaches, menstrual cramps, and muscle aches. Applied during phases of increased discomfort, this medication provides supportive relief when symptoms interfere with routine activities.

“It supports the patient during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable.”

By addressing symptoms related to physical discomfort and systemic imbalance, Vasco contributes to easing the overall symptom load during periods of heightened symptoms, supporting general well-being during symptomatic phases.


Quick Fact: Supportive assistance for Symptoms related to physical discomfort

Eligibility and Restrictions for Use

Who can and cannot use Vasco?

This section summarizes the official population eligibility and non-eligibility constraints for Vasco (Ascorbic Acid), based strictly on regulatory documents.

Eligibility Scope

Classification Populations Covered by Regulatory Label
Use is Established Adults, Children, Infants, and Older Adults for standard use. Pregnant and Lactating Women are permitted at standard nutritional doses.
Contraindicated Individuals with known hypersensitivity to Ascorbic Acid or excipients. Patients with a history of oxalate renal stones or hyperoxaluria, particularly when using high-dose preparations.

Eligibility-Related Restrictions

  • Conditional Use is necessary for patients with severe renal impairment due to the risk of oxalate crystal deposition.
  • Restriction on High Doses applies to patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the risk of hemolysis.
  • Caution is advised for patients with iron-overload conditions such as hereditary hemochromatosis due to enhanced iron mobilization.

Connection to the overall eligibility profile: Official documents define eligibility by establishing absolute non-eligibility for individuals with allergic risk and metabolic conditions that predispose them to oxalate buildup. Use is broadly established across all age and physiological groups, with restrictions primarily applying to specific high-risk patients when receiving high-dose or intravenous administration.

What should I know about interactions with other medicines?

Vasco (Ascorbic Acid) has officially documented interaction patterns primarily involving changes to other substances' absorption, clearance, or activity, as noted in government regulatory labeling.

Interactions Requiring Timing Separation or Caution Co-administration with Aluminum-containing Antacids must be separated in time to prevent an increase in aluminum absorption, a pharmacokinetic interaction that raises systemic aluminum exposure. Official guidelines require Ascorbic Acid to be taken at least two hours before or four hours after the antacid dose. Case reports also suggest potential interference with the anticoagulation effects of Warfarin.

Effects on Clearance and Activity Ascorbic Acid is documented to acidify the urine, which can increase the clearance and therefore lower the plasma concentrations of certain medicines, including Amphetamine and Fluphenazine. Furthermore, it may decrease the activity of certain antibiotics (e.g., Erythromycin, Kanamycin). Regulatory documents also note that Bleomycin is inactivated in vitro by Ascorbic Acid.

Interactions with Supplements and Specific Populations Ascorbic Acid inhibits the gastrointestinal absorption of oral Copper supplements. Specific cautions are noted for patients with G6PD Deficiency, where there is an officially documented increased risk for severe hemolysis, often necessitating a reduced dose. Additionally, the risk for oxalate nephropathy (kidney stone formation) is officially considered heightened in geriatric patients and those with renal impairment.

Mechanism of Action

Vasco is a sympathomimetic agent that exerts its effect primarily through its role as an alpha-adrenoceptor agonist on vascular smooth muscle. The drug binds to alpha1-adrenoceptors, which are Gq-protein coupled receptors located on the cell membrane of smooth muscle cells, particularly within the systemic arterial (resistance) and venous (capacitance) circulations.

Binding of Vasco to the alpha1-adrenoceptor initiates the Gq signaling cascade. This coupling activates phospholipase C (PLC), which catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate ( PIP2) into inositol trisphosphate ( IP3) and diacylglycerol (DAG).

Intracellularly, IP3 diffuses to the sarcoplasmic reticulum (SR) and binds to IP3 receptors, triggering the release of stored calcium ions ( Ca^2+) into the cytosol. The resultant elevation in cytosolic Ca^2+ concentration leads to the formation of Ca^2+-calmodulin complexes. This complex activates myosin light-chain kinase (MLCK), which phosphorylates myosin light chains. Myosin-light chain phosphorylation facilitates the interaction between actin and myosin filaments, resulting in vascular smooth muscle contraction.

At the system level, this widespread vasoconstriction of resistance vessels increases systemic vascular resistance (SVR), while constriction of capacitance vessels increases venous return and cardiac preload. The combined effect modulates mean arterial pressure by increasing the total peripheral resistance component.

Dosage and Administration Information

How to Use Vasco

Vasco, which contains Ascorbic Acid (Vitamin C), is administered via oral and parenteral routes, including intravenous (IV), intramuscular (IM), and subcutaneous (SC) injection. The choice of route depends on the patient's condition; the oral form is used for long-term supplementation, while the parenteral routes are generally reserved for short-term use when oral intake is compromised.


Official Dosing and Administration Parameters

Parameter Standard Parameters
Route of Administration Oral and Parenteral (IV, IM, SC).
Adult Dosing (Treatment) Oral: 100 mg to 250 mg once or twice daily, or up to 500 mg daily. IV: 200 mg once daily.
Pediatric Dosing (IV) 100 mg daily (ages 1 to <11 years); 50 mg daily (ages 5 months to <12 months).
Frequency Once daily or in divided doses.
Duration of Use IV administration is strictly limited to one week for the 200 mg daily regimen.

Administration Conditions

Oral formulations may be taken with or without food. Injectable solutions, particularly those provided as a Pharmacy Bulk Package, require dilution prior to use to achieve the correct concentration and must be administered as a slow intravenous infusion. The IV solution must also be protected from light for stability. Dosing for women who are pregnant or lactating should not exceed the U.S. Recommended Dietary Allowance (RDA).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vasco

Evidence for Scurvy and Nutritional Support

Vasco, when applied for its original purpose, was studied for how its ingredients may relate to Vitamin C deficiency, a condition known as scurvy. The evidence foundation for this use is well-established in the scientific literature, spanning historical controlled trials that first studied the ingredient's nutritional properties, alongside modern nutritional intervention trials and observational settings. Research explored how outcomes related to systemic or functional imbalance evolved, such as changes in clinical signs like bleeding gums and measured differences in reported fatigue and weakness.

Studies on Supportive Healing and Anemia

The medicine was evaluated in studies focused on outcomes related to collagen synthesis, which was studied using physiological measures in tissue repair and bone healing settings. Findings were mixed across studies, however, particularly in populations where baseline nutritional status was observed. Additionally, Vasco was studied for its potential relationship to iron absorption rates in the context of anemia. Research so far suggests that this association may exist, but certainty remains low due to varying methodologies, and evidence quality varies across studies.


Evidence for Symptom Management and Inflammation

The research landscape for the other stated uses of Vasco is primarily focused on outcomes related to physical discomfort and studies relevant in trials assessing short-term or episodic symptom patterns. These studies mainly employ short-term, placebo-controlled trials designed to explore temporary physiological imbalance during acute episodes.

Studies on Arthritis and Joint Function

Vasco was studied in research contexts involving conditions such as arthritis. Researchers examined measured changes in symptoms, including pain intensity and functional limitations, over defined time intervals using standardized patient-reported outcomes. The research does not determine whether an individual will respond similarly, and long-term effects are not fully established for joint modification.

Research on Headaches and Acute Pain Episodes

For headaches and other acute or disruptive episodes, the research primarily consists of single-dose RCTs. Research explored outcomes describing episodic or acute changes, specifically focusing on measurements related to achieving pain-free status at two hours. The evidence, while substantial for acute pain relief, is limited regarding the long-term patterns associated with chronic or frequent use of such agents.

Key Studies & References

  1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - StatPearls - NCBI Bookshelf
  2. Vitamin C - The Nutrition Source (Ascorbic Acid and Iron Absorption/Wound Healing Context)
  3. Scurvy: An overlooked and easily treated cause of bleeding (Modern Case Report/Review on Clinical Outcomes)

Frequently Asked Questions (FAQ)

Common questions about Vasco (FAQ)


Q: Why do some people say Vasco is hard on the stomach?

A: Regulatory documents indicate that gastrointestinal side effects have been reported with Ascorbic Acid, especially when higher amounts are taken. These reported effects can include nausea, vomiting, heartburn, abdominal cramps, and diarrhea. If any side effects are bothersome or persist, consulting a healthcare professional is generally described in official drug information.


Q: Is Vasco considered a 'strong' medicine?

A: Vasco contains the active ingredient Ascorbic Acid, which is chemically the same as Vitamin C. Official product information classifies it as a Vitamin-C Preparation. It is not classified as a controlled substance by regulatory agencies.


Q: Can Vasco affect my sleep patterns?

A: Official information notes that changes in sleep patterns, such as insomnia (difficulty sleeping) and sleepiness, have been reported as adverse reactions. These reports are generally associated with taking high doses of Ascorbic Acid (typically 1 gram or more daily).


Q: Does Vasco interact with common pain relievers like ibuprofen?

A: While not all specific pain relievers are named, official regulatory sources indicate that Ascorbic Acid can interfere with the absorption of aspirin. Additionally, it is noted that high doses of Vitamin C may be associated with various drug effects. Consulting a healthcare provider about all current medications is noted in official guidance.


Q: How is the use of Vasco described for older adults?

A: The use of Ascorbic Acid is described for all age groups, including older adults, in official labeling. However, regulatory documents specifically note that the risk for oxalate nephropathy, a condition involving kidney stone formation, is considered higher in geriatric patients and those with existing kidney issues.


Q: Is it possible to take Vasco for a long time?

A: Oral forms of Ascorbic Acid are typically used for long-term supplementation. Regulatory documents do, however, impose strict limits on the duration of use for certain intravenous (IV) administration regimens, such as limiting one specific high-dose regimen to one week.


Q: Is there a generic version of Vasco available?

A: Yes, Vasco contains Ascorbic Acid, which is the chemical name for Vitamin C. This active ingredient is available in many generic and store-brand formulations that are approved by regulatory agencies.


Q: Why does the official leaflet list so many possible side effects for Vasco?

A: Regulatory agencies require drug manufacturers to provide comprehensive disclosure of all documented events. This means that drug leaflets must list all adverse events observed in clinical trials and those reported after approval, regardless of how rarely they occurred.


Q: Does Vasco cause problems with memory or concentration?

A: Memory or concentration problems are not commonly listed as specific adverse effects in regulatory information. However, general central nervous system effects such as dizziness, faintness, and fatigue have been reported.


Q: Is Vasco a controlled substance or addictive?

A: Vasco (Ascorbic Acid) is not classified as a controlled substance by regulatory authorities. It is widely available in different forms, including over-the-counter and prescription formulations.


Q: Are there different strengths or doses of Vasco available?

A: Yes. Ascorbic Acid is available in many different strengths and dosage forms. These include oral tablets, ranging from 100 mg up to 1 g, and various concentrations of injectable solutions, depending on the specific product and manufacturer.


Q: Is Vasco a daily medication or is it taken as needed?

A: The product is generally taken once daily or in divided doses for the treatment or prevention of Vitamin C deficiency (Scurvy). Its primary indication is not for acute, 'as needed' symptom management.


Q: Is it necessary to have routine blood tests while taking Vasco?

A: Routine monitoring is not always universally required. However, official documents mention the importance of monitoring plasma vitamin C levels in certain situations and recommend clinical monitoring, such as urinalysis, for patients who may be at risk for kidney stone formation.


Q: What should I do if a side effect of Vasco seems minor but persists?

A: Official drug information notes that consultation with a doctor or other healthcare professional is advised if any undesirable effects occur. It is noted to check with your healthcare professional if any side effects are bothersome or persist over time.


Q: How is the safety of Vasco monitored after it is approved?

A: After a medicine is approved, regulatory agencies continue to monitor its safety. This process involves the continuous collection and evaluation of reports of post-marketing adverse reactions from manufacturers, which can lead to updates in the official product labeling.


Q: Has Vasco been studied for use in children or teenagers?

A: Yes. Regulatory dosing information provides specific instructions for the use of Ascorbic Acid in infants, children, and adolescents. This information covers both oral and intravenous administration.


Q: Does Vasco interact with herbal supplements like St. John's Wort?

A: Interactions between Ascorbic Acid and St. John’s Wort have not been noted in current regulatory summaries. The product is, however, documented to interact with other substances, including certain aluminum-containing antacids and certain antibiotics.


Q: Is Vasco the same as the drug with the chemical name [Chemical name]?

A: Vasco is the brand name for the medication. The active ingredient within Vasco is Ascorbic Acid, which is chemically and biologically identical to Vitamin C.


Q: How long does Vasco stay in your system after you stop taking it?

A: The elimination half-life of Ascorbic Acid, which is the time it takes for half the drug to leave the system, varies depending on its concentration in the plasma. Absorbed amounts that are not metabolized by the body are primarily excreted by the kidneys.


Q: Are headaches a common initial side effect when starting Vasco?

A: Headache is listed in regulatory sources as a less common or rare side effect associated with Ascorbic Acid use. They have been reported primarily with high-dose use of the product.


Q: Does Vasco interact with oral contraceptives?

A: Official drug interaction summaries indicate that high doses of Ascorbic Acid may potentially increase the serum levels of estrogens when they are contained within oral contraceptives or hormone replacement therapies.


Q: Is it true that Vasco can affect blood pressure?

A: Ascorbic Acid preparations often contain sodium in their formulations. This is noted as a factor for individuals on a sodium-restricted diet or those with conditions like hypertension (high blood pressure) that require sodium restriction.


Q: What happens if someone accidentally takes too much Vasco?

A: Prolonged intake of high doses, typically exceeding 2 grams per day, may be associated with symptoms such as nausea, abdominal cramps, diarrhea, heartburn, and headache. In the event of potentially taking more than the recommended amount, consulting a healthcare professional is noted.


Q: What is the connection between Vasco and [A common lab value]?

A: Regulatory documents mention that high levels of Ascorbic Acid might affect the accuracy of certain clinical tests. These include blood glucose screening tests and stool tests designed to detect hidden blood (occult blood). It is also related to the measurement of Vitamin C status in plasma.


Q: Is Vasco used to treat more than one condition?

A: Yes. Vasco (Ascorbic Acid) is principally indicated for the prevention and treatment of scurvy. Additionally, it may be used for other purposes, such as supporting wound healing and contributing to the formation of red blood cells.


Q: Are there any long-term health risks associated with Vasco use?

A: Regulatory documents associate long-term use of high doses (exceeding 2,000 mg per day) with an increased risk of specific effects. The primary documented risk is the formation of oxalate kidney stones.

How should Vasco be stored and disposed of?

How to Store and Dispose of Vasco?

Because the official, product-specific labeling for Vasco is not publicly available in general regulatory databases, storage and disposal must strictly adhere to general pharmaceutical regulations.

  • Storage: Store Vasco according to the instructions on its original packaging. If no temperature is specified, the product must be kept at controlled room temperature. The container closure system must protect the product from contamination and external deterioration factors, such as light or moisture, if applicable.

  • Disposal: Do not dispose of Vasco by flushing it down a toilet or pouring it down a drain. All unused, expired, or unwanted medicine must be managed as pharmaceutical waste and disposed of according to federal, state, and local regulations. Consult your pharmacist or a drug take-back program for the most appropriate method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vasco found in:

A-Z Index: